Brewin Dolphin Wealth Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-26,500
| Closed | -$90.1K | – | 192 |
|
|
2018
Q3 | $90.1K | Hold |
26,500
| – | – | 0.05% | 95 |
|
|
2018
Q2 | $99.6K | Hold |
26,500
| – | – | 0.06% | 92 |
|
|
2018
Q1 | $108K | Hold |
26,500
| – | – | 0.07% | 88 |
|
|
2017
Q4 | $123K | Buy |
26,500
+17,500
| +194% | +$81.4K | 0.08% | 82 |
|
|
2017
Q3 | $63.9K | Buy |
+9,000
| New | +$63.9K | 0.04% | 89 |
|